Role of Chitin and Chitinase/Chitinase-Like Proteins in Inflammation, Tissue Remodeling, and Injury

被引:682
作者
Lee, Chun Geun [1 ]
Da Silva, Carla A. [1 ]
Dela Cruz, Charles S. [1 ]
Ahangari, Farida [1 ]
Ma, Bing [1 ]
Kang, Min-Jong [1 ]
He, Chuan-Hua [1 ]
Takyar, Seyedtaghi [1 ]
Elias, Jack A. [1 ]
机构
[1] Yale Univ, Sch Med, Dept Internal Med, Sect Pulm & Crit Care Med, New Haven, CT 06520 USA
来源
ANNUAL REVIEW OF PHYSIOLOGY, VOL 73 | 2011年 / 73卷
关键词
asthma; fibrosis; BRP-39/YKL-40; AMCase; chitotriosidase; ACIDIC MAMMALIAN CHITINASE; HUMAN CARTILAGE GLYCOPROTEIN-39; NECROSIS-FACTOR-ALPHA; CHITOTRIOSIDASE GENE-EXPRESSION; SERUM YKL-40 LEVEL; PARASITE CHITINASE; SECRETED GLYCOPROTEIN; MACROPHAGE ACTIVATION; RHEUMATOID-ARTHRITIS; INTERFERON-GAMMA;
D O I
10.1146/annurev-physiol-012110-142250
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The 18 glycosyl hydrolase family of chitinases is an ancient gene family that is widely expressed from prokaryotes to eukaryotes. In mammals, despite the absence of endogenous chitin, a number of chitinases and chitinase-like proteins (C/CLPs) have been identified. However, their roles have only recently begun to be elucidated. Acidic mammalian chitinase (AMCase) inhibits chitin-induced innate inflammation; augments chitin-free, allergen-induced Th2 inflammation; and mediates effector functions of IL-13. The CLPs BRP-39/YKL-40 (also termed chitinase 3-like 1) inhibit oxidant-induced lung injury, augments adaptive Th2 immunity, regulates apoptosis, stimulates alternative macrophage activation, and contributes to fibrosis and wound healing. In accord with these findings, levels of YKL-40 in the lung and serum are increased in asthma and other inflammatory and remodeling disorders and often correlate with disease severity. Our understanding of the roles of C/CLPs in inflammation, tissue remodeling, and tissue injury in health and disease is reviewed below.
引用
收藏
页码:479 / 501
页数:23
相关论文
共 154 条
[61]   Serum YKL-40 is increased in patients with hepatic fibrosis [J].
Johansen, JS ;
Christoffersen, P ;
Moller, S ;
Price, PA ;
Henriksen, JH ;
Garbarsch, C ;
Bendtsen, F .
JOURNAL OF HEPATOLOGY, 2000, 32 (06) :911-920
[62]   Serum YKL-40, a new prognostic biomarker in cancer patients? [J].
Johansen, JS ;
Jensen, BV ;
Roslind, A ;
Nielsen, D ;
Price, PA .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (02) :194-202
[63]   Increased serum YKL-40 in patients with pulmonary sarcoidosis - a potential marker of disease activity? [J].
Johansen, JS ;
Milman, N ;
Hansen, M ;
Garbarsch, C ;
Price, PA ;
Graudal, N .
RESPIRATORY MEDICINE, 2005, 99 (04) :396-402
[64]   Plasma YKL-40: A new potential marker of fibrosis in patients with alcoholic cirrhosis? [J].
Johansen, JS ;
Moller, S ;
Price, PA ;
Bendtsen, F ;
Junge, J ;
Garbarsch, C ;
Henriksen, JH .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1997, 32 (06) :582-590
[65]  
Johansen JS, 1999, ARTHRITIS RHEUM-US, V42, P2624, DOI 10.1002/1529-0131(199912)42:12<2624::AID-ANR17>3.0.CO
[66]  
2-K
[67]  
JOHANSEN JS, 1992, J BONE MINER RES, V7, P501
[68]  
Johansen JS, 2006, DAN MED BULL, V53, P172
[69]   Expression of YKL-40 by peritumoral macrophages in human small cell lung cancer [J].
Junker, N ;
Johansen, JS ;
Andersen, CB ;
Kristjansen, PEG .
LUNG CANCER, 2005, 48 (02) :223-231
[70]   Regulation of YKL-40 expression during genotoxic or microenvironmental stress in human glioblastoma cells [J].
Junker, N ;
Johansen, JS ;
Hansen, LT ;
Lund, EL ;
Kristjansen, PEG .
CANCER SCIENCE, 2005, 96 (03) :183-190